Precise DNA cleavage using CRISPR-SpRYgests
Your Content Goes Here The ability to precisely [...]
A Genomic Risk Score Identifies Individuals at High Risk for Intracerebral Hemorrhage
Your Content Goes Here Intracerebral hemorrhage (ICH) is [...]
Oxygen restriction’s effects on lifespan
Your Content Goes Here Oxygen restriction has been [...]
Development of an oral treatment that rescues gait ataxia and retinal degeneration in a phenotypic mouse model of familial dysautonomia.
Your Content Goes Here Familial dysautonomia (FD) is [...]
Clonal haematopoiesis and risk of chronic liver disease.
Your Content Goes Here Through advances in population-based [...]
Polygenic Scores Help Reduce Racial Disparities in Predictive Accuracy of Automated Type 1 Diabetes Classification Algorithms
Your Content Goes Here In a study, led [...]
Distinct patterns of emotional and behavioral change in child psychiatry outpatients during the COVID-19 pandemic
Your Content Goes Here This was the first [...]
Improving polygenic prediction in ancestrally diverse populations
Your Content Goes Here Polygenic risk scores (PRS) [...]
Identification of Genetic Variation Influencing Metformin Response in a Multi-Ancestry Genome-Wide Association Study in the Diabetes Prevention Program (DPP)
Your Content Goes Here Genome-wide significant loci for [...]
Sensitive periods in development and risk for psychiatric disorders and related endpoints: A systematic review of child maltreatment findings
Your Content Goes Here Childhood maltreatment increases the [...]
The Center for Genomic Medicine (CGM) comprises one of the largest and most vibrant hubs of genomic medicine research in the world. The CGM includes 46 faculty collaborating to define the ‘genomic medicine cycle’ – which envisages a genomics community seeking to advance research from basic genomics research to ultimately using genome information for diagnostics and targeted therapeutics. All of our investigators are faculty at Harvard Medical School, and many members of our community are also investigators at the Broad Institute of Harvard and MIT.
